BR100 Decreased By (-0.15%)
BR30 Decreased By (-0.11%)
KSE100 Decreased By (-0.06%)
KSE30 Decreased By (-0.17%)
AGHA 6.46 Increased By ▲ 0.01 (0.16%)
BECO 4.17 Increased By ▲ 0.01 (0.24%)
BML 58.50 Increased By ▲ 1.19 (2.08%)
BOP 28.23 Increased By ▲ 0.08 (0.28%)
CNERGY 12.46 Increased By ▲ 0.05 (0.4%)
CSIL 5.36 No Change ▼ 0.00 (0%)
FCCL 51.24 Decreased By ▼ -0.42 (-0.81%)
FFL 13.89 Decreased By ▼ -0.01 (-0.07%)
FNEL 1.09 Increased By ▲ 0.01 (0.93%)
KEL 5.70 Decreased By ▼ -0.02 (-0.35%)
KOSM 5.32 Decreased By ▼ -0.01 (-0.19%)
LOTCHEM 24.20 Decreased By ▼ -0.05 (-0.21%)
MLCF 89.42 Decreased By ▼ -0.22 (-0.25%)
NBP 155.90 Decreased By ▼ -0.67 (-0.43%)
NCPL 49.90 Increased By ▲ 2.88 (6.13%)
NPL 54.93 Increased By ▲ 2.97 (5.72%)
OGDC 299.26 Decreased By ▼ -0.75 (-0.25%)
PACE 9.30 Increased By ▲ 0.04 (0.43%)
PAEL 33.00 Decreased By ▼ -0.01 (-0.03%)
PIBTL 13.12 Decreased By ▼ -0.07 (-0.53%)
PPL 214.40 Increased By ▲ 0.08 (0.04%)
PRL 97.74 Decreased By ▼ -3.70 (-3.65%)
PTC 52.30 Increased By ▲ 0.06 (0.11%)
SSGC 23.07 Decreased By ▼ -0.08 (-0.35%)
TBL 9.00 Decreased By ▼ -0.09 (-0.99%)
TELE 7.00 Increased By ▲ 0.02 (0.29%)
TPL 22.16 Increased By ▲ 0.12 (0.54%)
TPLP 11.73 Increased By ▲ 0.04 (0.34%)
TREET 22.82 Increased By ▲ 0.02 (0.09%)
TRG 57.14 Increased By ▲ 0.01 (0.02%)
World

Singapore approves COVID-19 vaccine for children ages 5 to 11

Published Updated
By

SINGAPORE: Singapore will start COVID-19 vaccinations for children aged 5 to 11 years before the end of this year, its health ministry said late on Friday.

The Southeast Asian city-state has already vaccinated 87% of its 5.5 million populations, and authorities were rushing to get children vaccinated amid concerns over rising number of paediatric COVID-19 cases.

AstraZeneca to supply COVID-19 antibody cocktail to Singapore

The dosage used for children will be one-third of that used in adults, similar to the United States.

Currently, only Pfizer-BioNTech "Comirnaty" vaccine has been approved for children's usage in Singapore, the health ministry added.

Singapore has also signed a new supply agreement with Pfizer-BioNTech for the COVID-19 vaccine, it said, without specifying how many vials will be supplied.

Comments

Comments are closed for this article.